Collegium PharmaceuticalvsJohnson & Johnson

COLL and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

COLL

Collegium Pharmaceutical, Inc.

$25.22

Value $801M

-0.39%
COLL's page

Collegium Pharmaceutical (COLL) has a market value of $801M and Johnson & Johnson (JNJ) $683B. Over the last year, with dividends, COLL moved -45.2% and JNJ +47.9%. The P/E is 21.0 for COLL and 42.4 for JNJ. Dividend yield: COLL none, JNJ 1.86%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    COLL$801M

    JNJ$683B

    JNJ is 853 times COLL

  • Revenue, 12 months

    COLL$815M

    JNJ$99.3B

    JNJ is 122 times COLL

  • Net income, 12 months

    COLL$38M

    JNJ$16.1B

    JNJ is 422 times COLL

  • Operating margin

    COLL15.2%

    JNJ–

  • ROIC

    COLL19.2%

    JNJ12.4%

    6.8 points apart

  • P/E

    COLL21.0

    JNJ42.4

    JNJ is 2.0 times COLL

  • Dividend yield

    COLL0.0%

    JNJ1.9%

    1.9 points apart

  • 5-year return

    COLL+26.0%

    JNJ+99.3%

    73.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

COLL+26.0%

JNJ+99.3%

10015020025020222023202420252026
Returns by period
PeriodCOLLWith dividendsJNJWith dividends
1 year since November 14, 2025-45.2%Price -45.2%+47.9%Price +44.7%
3 years since November 16, 2023+0.4%+0.1% a yearPrice +0.4%+105.6%+27.2% a yearPrice +88.8%
5 years since November 15, 2021+26.0%+4.7% a yearPrice +26.0%+99.3%+14.8% a yearPrice +73.3%
10 years since November 16, 2016+55.8%+4.5% a yearPrice +55.8%+219.6%+12.3% a yearPrice +143.6%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

COLLCollegium PharmaceuticalJNJJohnson & Johnson

Valuation

COLLJNJ
Valuation
Price$25.22$283.47
Market value$801M$683B
Enterprise value (EV)–$711B
P/E21.042.4
P/E, 5-year median19.621.9
P/B2.78.4
EV/EBIT–40.1
Free cash flow yield42.0%3.0%

Results and growth

COLLJNJ
Results and growth
Revenue, 12 months$815M$99.3B
Net income, 12 months$38M$16.1B
Free cash flow, 12 months$336M$20.6B
Earnings per share, 12 months$1.20$6.59
Revenue growth, year on year23.6%6.1%
Revenue growth a year, past+20.3%over 5 years+2.7%over 5 years
EPS growth a year, past+17.9%over 5 years+14.9%over 5 years

Margins and returns on capital

COLLJNJ
Margins and returns on capital
Gross margin59.1%67.6%
Operating margin15.2%–
Net margin4.7%16.2%
ROIC19.2%12.4%
ROE12.8%19.7%

Balance sheet

COLLJNJ
Balance sheet
Cash$145M$17.2B
Total debt–$44.7B
Net debt / EBITDA–1.1
Interest cover1.6×18.0×

Dividends and buybacks

COLLJNJ
Dividends and buybacks
Dividend yield–1.9%
Dividend per share, 12 months–$5.28
Dividend growth a year, past–+5.3%over 5 years
Buyback yield3.1%0.9%
Shareholder yield3.1%2.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: COLL or JNJ

Didn't find what you were looking for?

Ask us
Which is bigger, Collegium Pharmaceutical or Johnson & Johnson?

By market value, Johnson & Johnson ($683B) is about 853.0 times Collegium Pharmaceutical ($801M), at today's prices.

How did COLL and JNJ stock do over the last 10 years?

Since November 16, 2016, COLL's price moved +55.8% and JNJ's +143.6%. With dividends: COLL +55.8% (+4.5% a year), JNJ +219.6% (+12.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, COLL or JNJ?

The dividend yield at today's price is none for Collegium Pharmaceutical and 1.86% for Johnson & Johnson. Over the last twelve months they paid – and $5.28 per share.

What is the P/E of COLL and JNJ?

At today's price, the P/E is 21.0 for COLL and 42.4 for JNJ. The median of the last five years was 19.6 and 21.9, which shows where each stands against its own past.

Which has the higher profit margins, Collegium Pharmaceutical or Johnson & Johnson?

Over the last twelve months, the net margin was 4.7% for Collegium Pharmaceutical and 16.2% for Johnson & Johnson, and the operating margin 15.2% and –. Revenue was $815M and $99.3B.

Which is the better investment, Collegium Pharmaceutical or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.